CAPR Stock Rallies After-Hours As Capricor Reaffirms Deramiocel Confidence Ahead Of Nov. 22 Decision; Says Application In Final Review
The U.S. Food and Drug Administration is slated to decide on approving Deramiocel for the treatment of DMD by November 22.